Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Precision Biosensor Inc. (335810:KRX), powered by AI.
Precision Biosensor Inc. is currently trading at ₩1,687. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Precision Biosensor Inc. on Alpha Lenz.
Precision Biosensor Inc.'s P/E ratio is -3.7.
“Precision Biosensor Inc. trades at a P/E of -3.7 (undervalued) with modest ROE of -34.3%.”
Ask for details →Precision Biosensor Inc. is a company that specializes in the development and manufacturing of diagnostic biosensors designed for healthcare applications. Its primary function involves creating innovative point-of-care diagnostic tools that significantly enhance the efficiency and accuracy of patient diagnostics in medical settings. The company is pivotal in the biomedical sector, contributing to advancements in rapid testing technologies that impact hospitals, clinics, and laboratories. Notably, Precision Biosensor Inc. focuses on merging cutting-edge biosensor technology with user-friendly devices, thus enabling healthcare professionals to make informed decisions swiftly. Within the financial market, the company plays a vital role by offering technological solutions that address the demands of modern healthcare systems for quick, reliable diagnostic outcomes.
“Precision Biosensor Inc. trades at a P/E of -3.7 (undervalued) with modest ROE of -34.3%.”
Ask for details →Precision Biosensor Inc. (ticker: 335810) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 102 employees. Market cap is $37.0B.
The current price is ₩1,687 with a P/E ratio of -3.69x and P/B of 1.13x.
ROE is -34.29% and operating margin is -27.01%. Annual revenue is $19.9B.